Effects of orally administered lavender essential oil on responses to anxiety-provoking film clips

Human Psychopharmacology

Volumn 24, Issue 4, 2009, Pages 319-330

  Bradley, Belinda F ^a   Brown, Stephen L ^b   Chu, Simon ^a   Lea, Robert W ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Anxiety; Electrodermal response; Heart rate; Heart rate variation; Lavender essential oil; Oral administration

Indexed keywords

LAVENDER OIL; PLACEBO; ANXIOLYTIC AGENT; ESSENTIAL OIL;

ADULT; AGED; ANXIETY; ARTICLE; AUDIOVISUAL EQUIPMENT; BREATHING RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTRODERMAL RESPONSE; FEMALE; HEART RATE; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; STATE TRAIT ANXIETY INVENTORY; TRANQUILIZING ACTIVITY; ADOLESCENT; AFFECT; BREATHING MECHANICS; CHEMISTRY; LAVENDER; MICROCAPSULE; MIDDLE AGED; PHOTOSTIMULATION; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; AFFECT; AGED; ANTI-ANXIETY AGENTS; ANXIETY; CAPSULES; DOUBLE-BLIND METHOD; FEMALE; GALVANIC SKIN RESPONSE; HEART RATE; HUMANS; LAVANDULA; MALE; MIDDLE AGED; OILS, VOLATILE; PHOTIC STIMULATION; RESPIRATORY MECHANICS; YOUNG ADULT;

EID: 68049143084     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1016     Document Type: Article

References (74)

1. Akhondzadeh S, Kashani, L, Fotouhi A, et al. 2003. Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 27: 123-127.
2. Aoshima H, Hamamoto K. 1999. Potentiation of GABA(A) receptors expressed in Xenopus oocytes by perfume and phytoncid. Biosci Biotechnol Biochem 63: 743-748.
3. Atanassova-Shopova S, Roussinov KS. (1970) On certain central neurotropic effects of lavender essential oil. Izv Inst Fiziol (Sofiia) 13: 69-77.
4. Barocelli E, Calcina, F, Chiavarini M, et al. 2004. Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon "Grosso" essential oil. Life Sci 76: 213-223.
5. Berntson G, Bigger T, Eckberg DL, et al. 1997. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 34: 623-648.
6. Blechert J, Lajtman M, Michael T, Margraf J, Wilhelm FH. 2006. Identifying anxiety states using broad sampling and advanced processing of peripheral physiological information. Biomed Sci Instrum 42: 136-141.
7. Boiten FA. 1998. The effects of emotional behaviour on components of the respiratory cycle. Biol Psychol 49: 29-51.
8. Bradley BF, Starkey NJ, Brown SL, Lea RW. 2007. Anxiolytic effects of Lavandula angustifolia odour on the Mongolian gerbil elevated plus maze. J Ethnopharm 111: 517-525.
9. Brito-Zurita OR, Posadas-Romero C, Hermosillo AG, et al. 2003. Estrogen effect on heart rate variability in hypertensive postmenopausal women. Maturitas 44: 39-48.
10. Brosschot JF, Van Dijk E, Thayer JF. 2007. Daily worry is related to low heart rate variability during waking and the subsequent nocturnal sleep period. Int J Psychophysiol 63: 39-47.
11. Buchbauer G, Jirovetz L, Jager W, Plank C, Dietrich H. 1993. Fragrance compounds and essential oils with sedative effects upon inhalation. J Pharm Sci 82: 660-664.
12. Burnett KM, Solterbeck LA, Strapp CM. 2004. Scent and mood state following an anxiety-provoking task. Psychol Rep 95: 707-722.
13. Cacioppo J, Tassinary L. 1999. Principles of Psychophysiology. Physical, Social and Inferential Elements. Cambridge University Press: Avenue of the Americas, New York, USA.
14. Delaveau P, Guillemain J, Narcisse G, Rousseau A. 1989. Sur les propriétés neuro-dépressives de l'huile essentiale de Lavande. Neurophysiologie 183: 342-348.
15. Elisabetsky E, Marschner J, Souza DO. 1995. Effects of Linalool on glutamatergic system in the rat cerebral cortex. Neurochem Res 20: 461-465.
16. File SE, Kenny PJ, Cheeta S. 2000. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharm Biochem Behav 66: 65-72.
17. Friedman BH, Thayer JF. 1998. Autonomic balance revisited: panic anxiety and heart rate variability. J Psychosom Res 44: 133-151.
18. Ghelardini C, Galeotti N, Salvatore G, Mazzanti G. 1999. Local anaesthetic activity of the essential oil of Lavandula angustifolia. Planta Med 65: 700-703.
19. Gorman JM, Sloan RP. 2000. Heart rate variability in depressive and anxiety disorders. Am Heart J 140: 77-83.
20. Graeff FG, Parente A, Del Ben, CM, Guimaraes FS. 2003. Pharmacology of human experimental anxiety. Braz J Med Bio Res 36: 421-432.
21. Gray JA, McNaughton N. 2003. The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-hippocampal System, 2nd edn. Oxford University Press: New York, USA.
22. Gray EK, Watson D. 2007. Assessing positive and negative affect via self report. In The Handbook of Emotion Elicitation and Assessment, Coan JJ JA, Allen, B (eds). Oxford University Press: New York; 171-183.
23. Gross JJ, Levenson RW. 1995. Emotion elicitation using films. Int J Neurosci 9: 87-108.
24. Haglund MEM, Nestadt PS, Cooper NS, Southwick SM, Charney DS. 2007. Psychobiological mechanisms of resilience: relevance to prevention and treatment of stress-related psychopathology. Dev Psychopathol 19: 889-920.
25. Henley, DV, Lipson N, Korach KS, Bloch CA. 2007. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med 356(5): 479-485.
26. Heuberger E, Redhammer S, Buchbauer G. 2004. Transdermal absorption of (-)-linalool induces autonomic deactivation but has no impact on ratings of well-being in humans. Neuropsychopharmacology 29: 1925-1932.
27. Howell DC. 2002. Statistical Methods for Psychology, 5th edn. Thomson Learning: Duxbury.
28. Jaeger, W, Buchbauer, G, Jirovetz, L, Fritzer, M. 1992. Percutaneous absorption of lavender oil from a massage oil. J Soc Cos Chem 43: 49-54.
29. Johnsen BH, Thayer JF, Laberg JC, et al. 2003. Attentional and physiological characteristics of patients with dental anxiety. J Anx Disord 17: 75-87.
30. Kennedy DO, Scholey AB, Tildesley NTJ, Perry EK, Wesnes KA. 2002. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav 72: 953-964.
31. Kinrys G, Wygant LE. 2005. Anxiety disorders in women: does gender matter to treatment? Rev Bras Psiquiatr 27: s43-s50.
32. Kornstein SG, Schatzberg, AF, Thase ME, et al. 2000. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 157(9): 1445-1452.
33. Koto R, Imamura M, Watanabe C, et al. 2006. Linalyl acetate as a major ingredient of lavender essential oil relaxes the rabbit vascular smooth muscle through dephosphorylation of myosin light chain. J Cardiovasc Pharmacol 48: 850-856.
34. Kreibig SD, Wilhelm FH, Roth WT, Gross JJ. 2007. Cardiovascular, electrodermal, and respiratory response patterns to fear- and sadness-inducing films. Psychophysiology 44: 787-806.
35. Lang PJ, Davis M, Ohman A. 2000. Fear and anxiety: animal models and human cognitive psychophysiology. J Affect Disord 61: 137-159.
36. Lehrner J, Marwinski G, Lehr S, Johren P, Deecke L. 2005. Ambient odours of orange and lavender reduce anxiety and improve mood in a dental office. Physiol Behav 86(1-2): 92-95.
37. Lis-Balchin M, Hart S. 1999. Studies on the mode of action of the essential oil of lavender (Lavandula angustifolia P. Miller). Phytother Res 13: 540-542.
38. Malik M, Bigger J, Camm J, et al. 1996. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17: 354-381.
39. Malizia AL. 2002. Receptor binding and drug modulation in anxiety. Eur Neuropsychopharmacol 12: 567-574.
40. Martenyi F, Dossenbach M, Mraz, K, Metcalfe S. 2001. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur Neuropsychopharmacol 11: 227-232.
41. Matuszewich L, Karney JJ, Carter SR, Janasik SP, O'Brien JL, Friedman RD. 2007. The delayed effects of chronic unpredictable stress on anxiety measures. Physiol Behav 90: 674-681.
42. McCraty R, AtkinsonM, TillerWA, Rein G,Watkins AD. 1995. The effects of emotions on short-term power spectrum analysis of heart rate variability. Am J Cardiol 76: 1089-1093.
43. McEwen BS, Alves SE. 1999. Estrogen actions in the central nervous system. Endocr Rev 20: 279-307.
44. Mercuro G, Podda A, Pitzalis L, et al. 2000. Evidence of a role of endogenous estrogen in the modulation of autonomic nervous system. Am J Cardiol 85: 787-789.
45. Moss M, Cook J, Wesnes K, Duckett P. 2003. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. Int J Neurosci 113: 15-38.
46. Niskanen J-P., Tarvainen MP, Ranta-aho PO, Karjalainen PA. 2004. Software for advanced HRV analysis. Comput Meth Programs Biomed 76: 73-81.
47. Peana AT, De Montis MG, Nieddu E, Spano MT, D'Aquila PS, Pippia P. 2004. Profile of spinal and supra-spinal antinociception of (-)-linalool. Eur J Pharmacol 485: 165-174.
48. Penttila J, Helminen A, Jartti T, et al. 2001. Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: effects of various respiratory patterns. Clin Physiol 21: 365-376.
49. Price S, Price L. 1999. Stress. In Aromatherapy for Health Professionals, 2nd edn. Churchill Livingstone: London; 207-215.
50. Rottenberg J, Ray, RR, Gross JJ. 2007. Emotion elicitation using films. In The Handbook of Emotion Elicitation and Assessment, Coan JA, Allen, JJB (eds). Oxford University Press: New York; 9-28.
51. Saeki Y. 2000. The effect of foot-bath with or without the essential oil of lavender on the autonomic nervous system: a randomized trial. Complement Ther Med 8: 2-7.
52. Schnaubelt K. 1998. Advanced Aromatherapy, the Science of Essential Oil Therapy. Healing Arts Press: Rochester.
53. Shellie R, Mondello L, Marriott P, Dugo G. 2002. Characterisation of lavender essential oils by using gas chromatography-mass spectrometry with correlation of linear retention indices and comparison with comprehensive two-dimensional gas chromatography. J Chromatog A 970: 225-234.
54. Siegel S, Castellan NJ. 1998. Nonparametric Statistics for the Behavioural Sciences, 2nd edn. McGraw Hill: Maidenhead; 190-223.
55. Sinclair L, Nutt D. 2007. Anxiolytics. Psychiatry 6: 284-288.
56. Smith JC, Bradley MM, Lang PJ. 2005. State anxiety and affective physiology: effects of sustained exposure to affective pictures. Biol Psychol 69: 247-260.
57. Spielberger C, Gorusch R, Lushene R, Vagg P, Jacobs G. 1983. State-trait Anxiety Inventory for Adults. Mind Garden Inc.: California.
58. Stern R, Ray W, Quigley K. 2001. Psychophysiological Recording, 2nd edn. Oxford University Press: New York.
59. Tabachnick B, Fidell SL. 2001. Using Multivariate Statistics, 4th edn. Allyn and Bacon: Ohio, USA.
60. Tanida M, Niijima A, Shen J, Nakamura T, Nagai K. 2006. Olfactory stimulation with scent of lavender oil affects autonomic neurotransmission and blood pressure in rats. Neurosci Lett 398: 155-160.
61. Teuscher E, Melzig M, Villmann E. 1989. Components of essential oils as membrane -active compounds. Planta Med 55: 660.
62. Teuscher E, Melzig M, Villmann E, Moritz KU. 1990. Experiments concerning the mechanisms of action of essential oils. Z Phytother 11: 87-892.
63. Thayer JF, Friedman BH. 2002. Stop that! Inhibition, sensitization, and their neurovisceral concomitants. Scand J Psychol 43: 123-130.
64. Thayer, JF, Lane, RD. 2007. The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol 74(2): 224-242.
65. Tildesley NTJ, Kennedy DO, Perry EK, et al. 2003. Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers. Pharmacol Biochem Behav 75: 669-674.
66. Totten GL France CR. 1995. Physiological and subjective anxiety responses to caffeine and stress in nonclinical panic. J Anx Dis 9: 473-488.
67. Umezu T, Nagano K, Ito H, Kosakai K, Sakaniwa M, Morita M. 2006. Anticonflict effects of lavender oil and identification of its active constituents. Pharmacol Biochem Behav 85(4): 713-721.
68. van der Watt G, Laugharne J, Janca A. 2008. Complementary and alternative medicine in the treatment of anxiety and depression. Curr Opin Psychiatry 21: 37-42.
69. Vaswani, M, Linda, FK, Ramesh, S. 2003. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog in Neuro-Psychopharmacol Biol Psych 27: 85-102.
70. Watkins LLP, Grossman PP, Krishnan RM, Sherwood AP. 1998. Anxiety and vagal control of heart rate. Psychosom Med 60: 498-502.
71. Watson D. 1988. The vicissitudes of mood measurement: effects of varying descriptor time frames and response formats on measures of positive and negative affect. J Pers Soc Psychol 55: 128-141.
72. Watson D, Clark LA, Tellegen A. 1988. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54: 1063-1070.
73. Weber ST, Heuberger E. 2008. The impact of natural odors on affective states in humans. Chem Senses 33(5): 441-447.
74. Yamada K, Mimaki Y, Sashida Y. 2005. Effects of inhaling the vapor of Lavandula burnatii super-derived essential oil and linalool on plasma adrenocorticotropic hormone (ACTH), catecholamine and gonadotropin levels in experimental menopausal female rats. Biol Pharm Bull 28: 378-379.